Home / Companies / Taro Pharmaceutical Industries Ltd. / 28 Dec 2023
Taro Pharmaceutical Industries Ltd.: meeting of 28 Dec 2023
Votes reported on Form N-PX, item by item
64 Form N-PX filers reported votes at the Taro Pharmaceutical Industries Ltd. meeting of 28 Dec 2023. Their records fall into 6 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
6 nominees; 73.8% of reported votes for; 48 filers withheld from or voted against at least one nominee.
660 vote records from 61 filers. 8 of the 54 filers that marked the item either way voted against management. 7 filers reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
2 vote records from 2 filers. 0 of the 1 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
109 vote records from 60 filers. 0 of the 53 filers that marked the item either way voted against management. 7 filers reported this item without a management mark.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
110 vote records from 61 filers. 42 of the 54 filers that marked the item either way voted against management. 7 filers reported this item without a management mark.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
10 vote records from 5 filers. No filer marked a management recommendation, so no against-management figure is reported. 5 filers reported this item without a management mark.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
99 vote records from 55 filers. No filer marked a management recommendation, so no against-management figure is reported. 55 filers reported this item without a management mark.
How the largest families voted
| Family | 1. Directors | 3. Auditor |
|---|---|---|
| Vanguard | For | For |
| BlackRock and iShares | For | For |
| Fidelity | For | For |
| Dimensional | Split or no vote | Split or no vote |
| State Street and SPDR | For | For |
| American Century | For | For |
| Invesco | For | For |
| Equitable | For | For |
| Charles Schwab | For | For |
| Nuveen and TIAA | Against * | For |
| ProShares and ProFunds | For | For |
| John Hancock and Manulife | For | For |
| Morgan Stanley, Eaton Vance and Calvert | Against * | For |
| Goldman Sachs | For | For |
| Jackson National funds | Split or no vote | Split or no vote |
| Northern Trust and FlexShares | For | For |
| SEI | For | For |
| T. Rowe Price | For | For |
| Lincoln Financial | For | For |
| Voya | Against * | For |
| Nationwide | For | For |
| Brighthouse Funds | For | For |
| Guggenheim and Rydex | For | For |
| Columbia Threadneedle | For | For |
| Principal | For | For |
| Pacific Life funds | For | For |
| DWS | For | For |
| VanEck | For | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Taro Pharmaceutical Industries Ltd. meeting?
64 Form N-PX filers reported votes at the meeting of 28 Dec 2023. On say-on-pay, 0 of 1 voted against management (0.0%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Taro Pharmaceutical Industries Ltd. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Taro Pharmaceutical Industries Ltd.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Taro Pharmaceutical Industries Ltd. with a meeting date within three days of 28 Dec 2023. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.